Our Foundation Models

Industry-leading foundation models, built with pathologists in-the-loop

Mayo Clinic collaboration

Atlas foundation model

Atlas is our first pathology foundation model co-developed in collaboration with Mayo Clinic. It was engineered with our unique “pathologists in-the-loop” approach, ensuring that medical expertise was integrated at every stage of development. Atlas demonstrates industry-leading performance across 21 public benchmarks.

1.2M
Slides
100+
Staining types
490k
Cases
70+
Tissue types
7
Scanner types
Mayo Clinic & Charité Berlin
Development partners

Why use a foundation model?

/Case Study 1

Higher accuracy and efficiency

Foundation models improve accuracy and reduce the amount of training data required to build downstream applications.

/Case Study 1

Enhanced generalizability

Downstream applications built with foundation models generalize well to real world conditions (e.g., across scanners and labs such that additional “fine-tuning” is often unnecessary.

/Case Study 1

Better performance for rare diseases

Building high performing applications for rare diseases is often a challenge due to a lack of training data. Foundation models can help mitigate this via “anomaly detection.”

A timeline of our foundation models

Today

January 2024

Aignostics releases its first foundation model, RudolfV, which sets a new standard for performance as measured by public benchmarks.

October 2024

Aignostics announces strategic collaboration with Mayo Clinic to develop foundation models and products for research and clinical use.

January 2025

Aignostics announces Atlas, its first foundation model developed in collaboration with Mayo Clinic. As with RudolfV, Atlas sets a new standard for performance.

Today

Future

Aignostics is building a range of research offerings with Atlas that are geared toward biopharma. In addition, Aignostics and Mayo Clinic are co-developing even more powerful foundation models that will unlock new products for researchers and clinicians.

Future

Aignostics is building a range of research offerings with Atlas that are geared toward biopharma. In addition, Aignostics and Mayo Clinic are co-developing even more powerful foundation models that will unlock new products for researchers and clinicians.

Flexible licensing options tailored for your unique needs

We offer a variety of licensing options to fit your specific requirements, ensuring you get the most out of our Foundation Models. Our packages include customization and dedicated support.

  • Customizable licensing timelines to suit your project needs
  • Comprehensive support package for seamless integration
  • Flexible terms to adapt as your needs evolve

Unlock the power of biomedical data.

At Aignostics, we're transforming complex biomedical data into actionable insights that drive innovation in healthcare. Stay connected with us and be the first to learn how we’re shaping the future of medicine through data-driven solutions.